Ocata Therapeutics Inc (NASDAQ:OCAT)

6.63
Delayed Data
As of 3:59pm ET
 +0.01 / +0.15%
Today’s Change
4.95
Today|||52-Week Range
12.73
+8.87%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close6.62
Today’s open6.56
Day’s range6.56 - 6.79
Volume105,192
Average volume (3 months)152,726
Market cap$227.7M
Dividend yield--
Data as of 3:59pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-51.77%
P/E ratioNM
Price/Sales683.37
Price/Book15.23

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...+0.12+1.09%
ATHXAthersys Inc+0.10+3.47%
POZNPOZEN Inc0.000.00%
TRVNTrevena Inc+0.03+0.54%
Data as of 3:59pm ET, 03/06/2015

Financials

Last reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$225.0K
Annual profit (last year)-$31.0M
Net profit margin-13,788.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account